Current Edition

data

Khondrion Presents Phase II KHENERGY Trial Data

Khondrion, a leading clinical-stage pharmaceutical company focusing on small molecule therapeutics for mitochondrial diseases, today announced results from its KHENERGY study, a Phase II exploratory …

Continue Reading →
Alzheimer

First Ever Effective Intervention Against Dementia Shown in Large Study

Researchers just published the first randomized controlled trial ever to show an intervention effective at lowering the risk of dementia.  A computerized brain exercise licensed …

Continue Reading →